Background: Since the beginning of 2008, the implementation of a 100% activity-based payment system, has made efficiency one of the prime concern for the French health-care providing institutions. We therefore assessed the real cost of a scheduled total hip replacement (THR) in a teaching hospital and compared findings with French national data (and with the Government Healthcare Insurance System allowance). Hypothesis: The study should suggest possible means to optimize organization of management and/or clinicians' practice. Material and methods: This is a retrospective full-cost economic study. Patients were included only if fulfilling the following criteria: admitted in 2006; classified in Diagnosis-Related Group (DRG) 08C23 V or 08C23W (respectively THR without and with associated comorbidity); treated in a single department; admitted from home; and having undergone a THR (coded as NEKA020 in the french CPT) that same year. Treatment-cost was established on the basis of data collected from two main sources: the Information Systems Medicalization Program (ISMP) data-base, and the finance department data, which were taken into account in line with the French National Costs Study (NCS) structure.
Introduction
As part of the financial reform package (activity-based funding [ABF]), French health-care establishments (medical, surgical and obstetric [MSO] ) are having to implement new managerial approaches. Notably, they need to know their own production costs, as they are required to draw up an annual Provisional statement of income and expenditure (PSIE). The Lariboisière-Fernand-Widal hospital group, a Paris teaching hospital, faces the same challenges as all other French public health-care establishments with respect to its MSO activity.
As far as income is concerned, each admission is classified in a Diagnosis-related group (DRG) by the Information Systems Medicalization Program (ISMP). Each DRG has a nationally established price attributed to it (with weighting in certain geographical regions), corresponding to the payment the establishment can receive for the stay [1] . Prices are set at national level, based on the data of the National Costs Study (NCS), conducted by some 50 volunteer institutions.
Since ABF came to be implemented across the board in 2008, more than half of the income of hospitals has come directly from admissions.
To balance their finances, establishments also need to forecast and, if required, control their costs. However, the accountancy practiced in French public health-care establishments is not such as to allow fine-grained analysis of the costs entailed by treating patients and pathologies. There is a tool, called the Case-Mix Costs table (CMCT), which, according to the Hospital Expertise and Audit Mission (MEAH), ''enables the MSO activity costs of a given health-care establishment to be compared to a virtual establishment with exactly the same activity measured in terms of DRGs but with production costs calculated from the unit costs identified in the NCS'' [2] . Applying this at the level of the hospital, section or department allows cost lines diverging from the national average to be highlighted. The degree of information compaction, however, is too high to allow clinicians to design any concrete improvement plans. If, for example, costs incurred by the use of technical platforms are above the national average, there is nothing to show whether this finding concerns the whole range of pathologies managed in the department, section or hospital or just certain specific pathologies. Since clinical departments rarely have any time to organize a review of their files on such a topic, such a finding will probably not lead to anything actually being done.
The present study sought to lay the foundations for a simple, reproductible methodology for assessing total management costs for a given pathology on the basis of existing medico-administrative data. The aim was to enable hospital departments that do not have NCS-type analytic accountancy to know the costs of managing the main pathologies they deal with and make comparisons with national mean values. Implementing the approach would first of all enable the costs involved in the department/hospital's main activities to be calculated. Secondly, the professionals concerned could then identify the costlines on which marginal efficiency might be achieved in terms of treatment organization. Detailed information and comparison to national-level data form a preliminary phase prior to reflection concerning treatment organization and practices. The final objective is to improve efficiency. Such a study might also improve cooperation between management and physicians [3] .
Total hip replacement (THR) was selected as focus, firstly, as being frequent, at about 12.9% of our orthopedic department's activity in 2007 (DRG of THR with or without associated comorbidity); and secondly, in the light of population aging [4] and of our section's specialization in prosthetics in young patients, as offering considerable development potential.
Material and methods

Type of study and population
For the purposes of the study, we calculated the total cost [5] of a hospital stay, from the point of view of the hospital. The study was retrospective, con-cerning patients admitted for THR in the orthopedic surgery department of our hospital group during the year 2006. In the 10th DRG classification, such admissions come under DRG 08C23 V or 08C23W (respectively, ''Hip replacement without associated comorbidity'' and ''Hip replacement with associated comorbidity''). As this particular DRG classification was implemented in March 2006, the study period was limited to the last 9 months of that year.
DRGs are meant to be homogeneous in terms of resources, whereas there are a number of different item codes for THR. To obtain a homogeneous treatment cost, we therefore made the calculation for a ''standard'' patient group, defined by three criteria:
• type of surgery: unilateral THR without replacement of prosthesis, graft, osteotomy or reconstruction. The item chosen for the study was thus ''Hip joint replacement by total prosthesis'', coded NEKA020 on the 2nd version of the Common Classification of Medical Procedures (CCMP); • type of stay: single ward; the entire stay was within the same medical ward; • type of admission: patients admitted from Emergency or by transfer were excluded, and only those admitted from home (''Home Admission Mode'') were included.
Data collection
The study data-base was constructed from 3 computerized data-bases of the Paris Hospitals Board (Assistance 
Calculation of hospital stay costs
The two DRGs were distinguished for purposes of cost calculation. The itemization was that used in the 2005 National Costs Study, as found in the present Results Tables. This means that catering, laundry and maintenance costs were included, unlike in many other studies of hospital stay costs [6, 7, 8] .
Patients were admitted to the orthopedics department and managed in the in-patients ward and in theater. Costs for both of these sectors were analyzed, and calculated by the most appropriate Work Unit (WU). Table 1 presents the WUs, the data and the calculation for each cost item. Cost per day was calculated in terms of the number of invoicable administrative hospitalization days (used for financial data), so that the data would be homogeneous. Thus, each ''ISMP'' stay duration was increased by 1 day to obtain the administrative stay duration.
Certain NCS cost-lines were not used in the study: obstetric theater, dialysis, Emergency and mobile emergency and mobile intensive care unit (SMUR), intensive care, and external procedure costs. Our target cases were non-emergency single ward stays, and there was thus no involvement of departments other than orthopedics.
Results for the 2 DRGs were compared to the costs given by the NCS and the rates applied by the French National Health Insurance scheme (CPAM).
Results
Target population
In all, 57 admissions under DRG 08C23 V and 72 under 08C23W were included ( Fig. 1 ).
Figure 1
Target population with (08C23V) and without (08C23W) comorbidity for scheduled THR admission in 2006.
Cost of care in the hospital group and comparison to NCS values
Results are shown in Tables 2 and 3 . The monetary unit is the Euro. Care costs were D 7,529.19 for DRG 08C23 V and D 8,104.72 for DRG 08C23W, excluding the IMDs. Comparison with NCS data revealed the following differences:
• the mean hospital stay was shorter than in the NCS, for both DRG 08C23 V and DRG 08C23W (respectively, 8.8 vs 12.6 and 9.3 vs 16.9 days). According to type of discharge, mean stay was 2 days longer for patients referred to a rehabilitation center (42% of patients) than for those discharged home. Even in case of rehabilitation referral, mean stays were still shorter than in the NCS: respectively, 10.3 and 10.0 days for DRGs 08C23 V and 08C23W; • mean cost per patient was lower (by > 5%) than in the NCS in three areas: personnel, imaging and overheads; • mean catering and laundry costs per patient were comparable to NCS values for DRG 08C23W, as were mean catering and general logistics costs for DRG 08C23 V, while overheads costs were lower for both; • in contrast, mean medical logistics costs per patient (line 5) were significantly higher than in the NCS; smaller differences were also found for theater costs (line C) and ''Total medico-technical'' costs (line D); • finally, there was a difference of 15% or 25% (respectively, for DRGs 08C23W and 08C23 V) for consumables, medication and blood costs (line E).
Thus, care costs for our target DRGs (08C23W and 08C23 V) were higher than those found in the NCS and than the CPAM rate after application of the geographic coefficient.
Discussion Methodology
The methodology used to calculate care costs was based on the cost-structure of the 2005 French National Costs Scale. A Medline review was carried out in June 2008, using the MeSH keywords ''Arthroplasty, Replacement'', ''Cost and Cost Analysis'', and ''Arthroplasty, Replacement, Hip/economics'', to compare our methodology to others. It found no published studies with detailed calculation of total hospital THR management costs. Chamberlin et al. [6] determined the direct hospital cost of managing pertrochanteric fracture in the elderly, and Stargart [9] assessed differential primary THR costs across 9 EU member countries, but with insufficient methodological detail for comparison with the present results. Finally, the Rhône-Alpes Regional Union of Private Physicians (URMLRA) in France compared costs between three surgical procedures [10] . All in all, whether before or after the introduction of ABF, few such studies have been published. [4, 5] , although some of the cost-calculation methods presented in the above-mentioned MEAH report do show certain similarities to ours. 
Results
The cost differentials found here may have several causes. Firstly, we included only a certain number of the patients falling under our target DRGs. There are also other possible causes, which we shall examine by cost-sector.
Medical staff expenditure in the ward
The difference observed here is due to the combination of two factors. The first concerns how time is shared out between theater, consultations and the in-patients department. In our institution, each head of department draws up this distribution yearly for accountancy purposes, and it is not then objectified by any precise measurement of work-time spent on practitioners' various activities. Moreover, in this teaching hospital, the department is staffed by university-employed physicians, who cost the institution less than hospital-employed practitioners would: the hospital itself pays a university professor less than 60% of the salary it pays to a full-time hospital practitioner.
Medical expenditure (laboratory, imaging and consumables)
The total laboratory cost differential may have been due to the number of laboratory acts being higher than the national average, or to higher production costs. It therefore has to be determined whether this was a volume effect or a price effect. If it was a volume effect or prescriber effect (e.g., trainee physicians), this needs discussing with the clinicians as it is a question of practices. Imaging costs, in contrast, were half those of the NCS, for which there are two possible explanations. The available NCS data fail to distinguish between scheduled THR costs and those for THR secondary to fracture, which require more X-ray items. Moreover, Xray production costs may be lower in our institution than in the NCS institutions, or again our department's protocol may entail fewer X-rays. These points are currently under study. Finally, the cost differential in consumables, drugs and blood products (line E) may be due to the use of specific and more costly IMDs for younger patients (63.7 and 62.7 years, respectively for DRGs 08C23W and 08C23 V). It is to be noted that lack of available accountancy data prevented our costing the blood products actually used for the study patients; a mean cost for orthopedic department patients as a whole was used instead.
Other expenditure
The significant difference in medical logistics costs (line 5) compared to the NCS values may be due to how they are apportioned by AP-HP HQ, so that catering, laundry, general logistics and overheads vary from one establishment to another. On-going amortization of a new sterilization system may also enter into this differential.
The theater costs differential (line C) may correspond to a significant potential for productivity gains by optimizing theater occupation (as confirmed by a subsequent audit). Moreover, our accounting procedure included theatre logistics under the WU ''relative cost index'' (RCI), although this was inappropriate to the definition of RCI as the accountancy WU for medico-technical procedures. The RCI represents the human and material resources directly deployed in each CCMP procedure [11] . Our choice was due to the presence of such lines in the analytic accounts system we had available. Moreover, our analytic accounts system fails fully to distinguish IMDs paid for as extras (nails, cement, etc.), which may have increased the mean RCI cost. Furthermore, the significant difference in medico-technical procedure costs (line D) may be due to our having included rehabilitation procedures under line 19 (''Other medico-technical'') rather than line A (personnel expenditure).
Not all cost analyses take account of general expenditure [6, 7, 8] , although a useful database for this exists (the Angers data-base). Some studies, moreover, do not include a calculation of investment and amortization costs [8] . We chose to take these on board, as the PSIE was drawn up with these two elements taken into account. However, the specificity of the AP-HP, of which our hospital group is a part, must be borne in mind: HQ costs are spread over the 36 institutions making up the AP-HP. Expenses reduced to the ''day of hospital stay'' WU are strongly affected by the duration of the stay. The present mean stay durations were shorter than in the NCS and may mask mean daily stay costs that were higher. Also, the difference in mean stay duration according to type of discharge (home or rehab center) is worth examining in a dedicated study: the present research did not distinguish the two, and the issue is being addressed as part of the clinical trajectory analysis being undertaken in the orthopedics department at the time of writing.
Finally, the total costs for the two DRGs were almost identical, whereas 08C23W might have been expected to be more costly. Several hypotheses would be worth exploring, notably the relatively short duration of stays for 08C23W in our institution, despite perfectly standard management (the exactitude of the DRG coding having been double-checked). Further information will be needed in order to guide action.
Interest of the study
Working from existing data, we sought to determine the cost of a procedure that is homogeneous and frequent in our institution. Comparison between our calculated costs and those of the NCS and the CPAM rate [11] revealed certain differences. These findings, in turn, lead us to explore the reasons for such differences, in close collaboration with the departments concerned, whether administrative, medicotechnical or clinical.
The approach by cost-line helps target corrective action as part of the orthopedic department's quest for efficiency. Improved patient management should help optimize costs; Greater awareness of the interest of early standing and the precautions to be taken by the care-team, or again preplanned and more frequent intervention by physiotherapists, should combine to reduce mean hospital stay. This would reduce those costs that are directly bound to stay duration. Moreover, this activity-based rather than DRGbased approach is closer to that of the clinician, enabling physicians to be more actively involved in the search for solutions. This kind of approach may help guide the choice of issues in the assessment of professional practices: e.g., the relevance of prescribing complementary imaging and biological examinations.
Drawing up ''clinical trajectories'' [12] could help optimize management. Depending on the presenting pathology, a patient's care-trajectory within the establishment is determined as of admission. This presenting pathology, however, is not the sole relevant factor, as possible comorbidity and medico-psycho-social factors influence the indications for procedures and expert involvement along the trajectory, all of which impact stay duration. Such factors need to be taken into account at admission.
The study had the virtue of promoting a genuine partnership between the Public Health and Health Economics Department, the clinical department and the Finance Department, and this at a time when efficiency is being explicitly required of health-care establishments by the authorities. This work needs refining, with more precise calculation of personnel and consumables costs, which it is possible to detail per patient.
Study limitations
In the terms of the review of the medico-economic literature conducted by Bozic et al. [13] , the present study corresponds to the 58% of cost-identification studies and the 80% carried out from the point of view of the establishment. The results are to be taken with caution, as tendencies. Unlike certain cost analyses, we did not calculate either the hourly costs of medical and paramedical staff [11] and their distribution between theater and ward or exact costs for medical consumables and imaging [6, 7, 14] or laboratory examinations for target patients. It is worth noting that medical and paramedical activities are concentrated in the days directly following surgery. In other words, THR costs are not evenly spread over the stay. The Work Unit chosen for personnel costs in the present study is thus open to reflection. Moreover, the distribution of medical personnel costs between theater and ward depends on the distribution of medical personnel's work-time between the various sectors (consultation, theater and ward), which is self-reported.
The study was also based on data for activities as coded by the physicians themselves. The quality of this information depends upon exactitude and thoroughness of the coding. In 2006, the thoroughness of ISMP coding reached 100% in the orthopedics department.
Moreover, not all cases classified under the two DRGs were analyzed. Only ''single department'' stays were included, so as to have precise costs for the orthopedics department (theater and ward) alone, cost distribution being more complicated when patients change departments during their stay. Likewise, non-scheduled admissions were excluded, and their costs may tend to be higher. And finally, the DRGs 08C23 V and 08C23W were set up in March 2006, so that our studied concerned only the last 9 months of that year. All of these choices, however, had the advantage of analyzing costs on well-defined and homogeneous care procedures.
Difficulties encountered
Many difficulties can be expected during costs analysis, especially if the institution is not involved in the National Costs Study or does not practice fine-grained accountancy.
The first is to relate data on activity and on expenditure when the ISMP and finances are not cut up in the same way. Also, for certain items, our hospital group is dependent on how the AP-HP spreads its costs. Finally, some technical difficulties were encountered in using the various software programs, which leads us to call for using a single integrated package for all aspects of patient management.
Conclusion
Activity-based funding means that public health-care establishments need to evolve from expenditure-control management to cost-control management. Given the national rate applied to each stay, establishments need to know their production cost, at least for their main activities (in terms of volume and/or resources deployed), and especially those for which efficiency might be improved. The present study was conducted with this in mind. It is then up to those involved to work together with efficiency as their aim. We were able to highlight differentials with respect to national averages, excluding IMDs (7.5% in 08C23W and 24% in 08C23 V). The 7% differential with respect to the weighted CPAM rate (respectively −2% and −5.5%) was better, but too slight to be interpretable, given the above-mentioned study limitations. We are all too well aware of the fact that the lack of precise analytic accountancy data and the approximations which that imposed on us precludes any clear assertion as to whether THR costs in our hospital group are higher or lower than the national average, especially as regards the heavier cases classified as 08C23W. The present study did, however, manage to raise a certain number of questions, highlighting the complexity of assessing treatment costs. Our hospital group has decided to take part in the NCS, which should help provide more useful information. The study also helped identify points to which special attention should be paid in order to set up a process to improve THR patient management. It has been decided to draw up a clinical THR trajectory. This will be followed by a new costs analysis, to assess what progress has been made.
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